1 domain / 2 areas / 1 specialization
Apeiron Investment Group
Also known as: Apeiron
Data updated
Apeiron Investment Group is a discretionary investment firm founded and owned by Christian Angermayer. Its website says it manages approximately $7 billion and operates with teams in New York, London, Berlin, Abu Dhabi, and Malta, with a primary focus on the U.S. market.
It matters in the psychedelic ecosystem because Apeiron has been a recurring backer of atai Life Sciences, including co-leading atai's $125 million Series C financing in 2020 and its $50 million private placement financing in 2025. Apeiron's own website also describes psychedelics as a key part of its investment story and says it has been instrumental in the renaissance of psychedelics as treatments for mental health issues.
Investor Context
Venture CapitalInvestment Context
This stakeholder is listed as a Family Office within Venture Capital. Its public geography context is global. Public stage signals include Seed, Series A/B, and Growth / Late Stage. Public focus areas include Drug Development.
Public Portfolio Examples
- atai Life SciencesPrivate placement financing (co-led) - $50m financing - Jul 1, 2025
Apeiron Investment Group appears to be a multi-strategy family office style platform with direct investments across the company lifecycle, including incubating, accelerating, scaling, and supporting public companies. It describes itself as generally opportunistic while highlighting biotech, fintech and crypto, deep tech, experiences, real estate, and natural resources as areas of focus, and it explicitly frames psychedelic medicine as one of its defining themes through its longstanding association with atai Life Sciences.
Investor Type
Family Office
Geographic Scope
Global
Psychedelic Focus
Explicit Psychedelic Focus
Engagement
Active
Investment Stage Focus
Investment Focus Areas
Recorded Investments
Jul 1, 2025
Private placement financing (co-led) - $50m financing
atai $50m private placement financingNov 23, 2020
Series C financing (co-led) - $125m financing round
Date uses press release date.
ATAI closes $125m Series C financing roundQuick Facts
- HQ
- Abu Dhabi, United Arab Emirates
- Website
- Visit